FDA Inspection 998353 — American Red Cross Blood Services Southwest Region
The FDA completed an inspection of American Red Cross Blood Services Southwest Region on January 19, 2017 in Dallas, TX. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- January 19, 2017
- Fiscal Year
- 2017
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Dallas, TX (United States)